BAPINEUZUMAB (236-ALANINE,237-ALANINE,239-ALANINE) (HUMANIZED CLONE 3D6 .GAMMA.1-CHAIN)
Alzheimer's Disease
Pfizermonoclonal_antibodyPhase 1Dormant
CC
46/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 37/ 100
- Competitive Position
- 73/ 100
Competitive context
317 Active assets in the Alzheimer's Disease cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
4-((1E)-2-(6-(2-)2-(2-FLUOROETHOXY)ETHOXY)ETHOXY)PYRIDIN-3-YL)ETHENYL)-N-METHYLBENZENAMINE Akiva Mintz | Phase 4 | BBB |
Namenda Carnot Laboratories | Phase 4 | BBB |
Cipralex NYU Langone Health | Phase 4 | BBB |
6H-BENZOFURO(3A,3,2-EF)(2)BENZAZEPIN-6-OL, 4A,5,9,10,11,12-HEXAHYDRO-3-METHOXY-11-METHYL-, (4AS,6R,8AS) Anhui Provincial Hospital | Phase 4 | BBB |
PROPOFOL Nyree Penn | Phase 4 | BBB |
View all 50 →
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →